Olanzapine in the Management of Chorea
Olanzapine is an effective treatment option for chorea, particularly in severe cases, with evidence showing significant reduction in choreatic movements at doses of 10-30 mg daily. 1, 2
Mechanism and Efficacy
- Olanzapine is an atypical antipsychotic that antagonizes multiple receptors involved in movement disorders, including dopamine D2 receptors, which helps control choreatic movements 3
- High-dose olanzapine (up to 30 mg daily) has demonstrated remarkable efficacy in severe chorea, with rapid improvement in symptoms within days of initiation 1
- In Huntington's disease-related chorea, olanzapine has shown significant improvement in most subscores of the Unified Huntington's Disease Rating Scale (UHDRS), including fine motor tasks 2
- Recent analysis from the Enroll-HD database suggests that olanzapine may be comparable to tetrabenazine in controlling Huntington's chorea, with potentially less worsening of total motor scores over time 4
Dosing Considerations
- Starting doses typically range from 2.5-5 mg daily, with gradual titration based on response and tolerability 3
- For severe chorea, higher doses (up to 30 mg daily) may be required for optimal symptom control 1, 2
- Lower starting doses should be considered in elderly patients or those with hepatic impairment 3
- The sedative effects of olanzapine can be utilized advantageously by administering the highest daily dose at night to improve sleep disturbances that often accompany chorea 5
Clinical Applications Beyond Huntington's Disease
- Olanzapine may be beneficial in chorea associated with antiphospholipid antibodies/syndrome, though evidence is limited 6
- In systemic lupus erythematosus with neuropsychiatric manifestations, olanzapine can be considered for management of chorea, especially when other symptoms like weight loss are present 6, 5
Combination Therapy Approaches
- In severe chorea, combining olanzapine (a postsynaptic dopamine antagonist) with a presynaptic agent like tetrabenazine may provide synergistic effects 5
- When using olanzapine with other medications, be cautious about additive side effects, particularly excessive sedation and extrapyramidal symptoms 3
Monitoring and Side Effect Management
- Regular monitoring for extrapyramidal symptoms, metabolic effects (weight gain, hyperglycemia, dyslipidemia), and sedation is essential 3
- Olanzapine carries a lower risk of extrapyramidal side effects compared to typical antipsychotics, making it potentially advantageous for chorea patients who may be sensitive to these effects 3, 4
- Be vigilant for QTc prolongation, especially when combining with other medications that may affect cardiac conduction 3
Special Considerations
- Avoid combining olanzapine with benzodiazepines when possible, as fatalities have been reported with this combination 7
- Use caution in patients with Parkinson's disease or dementia with Lewy bodies due to increased risk of extrapyramidal symptoms 3
- Olanzapine may be particularly beneficial in patients with chorea who also experience weight loss, as it can help with weight gain 5
Treatment Algorithm for Chorea
- For mild to moderate chorea: Start with olanzapine 2.5-5 mg daily, titrate up based on response and tolerability 3, 2
- For severe chorea: Consider higher doses (10-30 mg daily) with close monitoring for side effects 1, 2
- For refractory cases: Consider combination therapy with a presynaptic agent like tetrabenazine 5
- For chorea with concurrent psychiatric symptoms: Olanzapine may provide dual benefit for both movement disorder and psychiatric manifestations 5